286 related articles for article (PubMed ID: 4014858)
1. Size aspects of metered-dose inhaler aerosols.
Kim CS; Trujillo D; Sackner MA
Am Rev Respir Dis; 1985 Jul; 132(1):137-42. PubMed ID: 4014858
[TBL] [Abstract][Full Text] [Related]
2. Aerodynamic particle size analysis of aerosols from pressurized metered-dose inhalers: comparison of Andersen 8-stage cascade impactor, next generation pharmaceutical impactor, and model 3321 Aerodynamic Particle Sizer aerosol spectrometer.
Mitchell JP; Nagel MW; Wiersema KJ; Doyle CC
AAPS PharmSciTech; 2003 Oct; 4(4):E54. PubMed ID: 15198549
[TBL] [Abstract][Full Text] [Related]
3. A correlation equation for the mass median aerodynamic diameter of the aerosol emitted by solution metered dose inhalers.
Ivey JW; Lewis D; Church T; Finlay WH; Vehring R
Int J Pharm; 2014 Apr; 465(1-2):18-24. PubMed ID: 24524827
[TBL] [Abstract][Full Text] [Related]
4. Inhalation delivery of anticancer agents via HFA-based metered dose inhaler using methotrexate as a model drug.
Shaik MS; Haynes A; McSween J; Ikediobi O; Kanikkannan N; Singh M
J Aerosol Med; 2002; 15(3):261-70. PubMed ID: 12396414
[TBL] [Abstract][Full Text] [Related]
5. Combining a positive expiratory pressure device with a metered-dose inhaler reservoir system using chlorofluorocarbon albuterol and hydrofluoroalkane albuterol: effect on dose and particle size distributions.
Rau JL; Torniainen M
Respir Care; 2000 Mar; 45(3):320-6. PubMed ID: 10771801
[TBL] [Abstract][Full Text] [Related]
6. Albuterol delivery in a model of mechanical ventilation. Comparison of metered-dose inhaler and nebulizer efficiency.
Diot P; Morra L; Smaldone GC
Am J Respir Crit Care Med; 1995 Oct; 152(4 Pt 1):1391-4. PubMed ID: 7551401
[TBL] [Abstract][Full Text] [Related]
7. Effect of inhalation flow rate on the dosing characteristics of dry powder inhaler (DPI) and metered dose inhaler (MDI) products.
Ross DL; Schultz RK
J Aerosol Med; 1996; 9(2):215-26. PubMed ID: 10163351
[TBL] [Abstract][Full Text] [Related]
8. Factors influencing the size distribution of aerosols from jet nebulisers.
Clay MM; Pavia D; Newman SP; Clarke SW
Thorax; 1983 Oct; 38(10):755-9. PubMed ID: 6648854
[TBL] [Abstract][Full Text] [Related]
9. Aerosol generation by metered-dose inhalers containing dimethyl ether/propane inverse microemulsions.
Sommerville ML; Hickey AJ
AAPS PharmSciTech; 2003 Nov; 4(4):E58. PubMed ID: 15198553
[TBL] [Abstract][Full Text] [Related]
10. Size distribution of chromate paint aerosol generated in a bench-scale spray booth.
Sabty-Daily RA; Hinds WC; Froines JR
Ann Occup Hyg; 2005 Jan; 49(1):33-45. PubMed ID: 15596421
[TBL] [Abstract][Full Text] [Related]
11. The influence of initial atomized droplet size on residual particle size from pressurized metered dose inhalers.
Sheth P; Stein SW; Myrdal PB
Int J Pharm; 2013 Oct; 455(1-2):57-65. PubMed ID: 23911912
[TBL] [Abstract][Full Text] [Related]
12. Probability of particle and salbutamol deposition in the respiratory tract: comparison between MDI and Autohaler.
Terzano C; Mannino F
Monaldi Arch Chest Dis; 1996 Jun; 51(3):236-42. PubMed ID: 8766201
[TBL] [Abstract][Full Text] [Related]
13. The development of a novel high-dose pressurized aerosol dry-powder device (PADD) for the delivery of pumactant for inhalation therapy.
Young PM; Thompson J; Woodcock D; Aydin M; Price R
J Aerosol Med; 2004; 17(2):123-8. PubMed ID: 15294062
[TBL] [Abstract][Full Text] [Related]
14. Aerosol deposition considerations in inhalation therapy.
Newman SP
Chest; 1985 Aug; 88(2 Suppl):152S-160S. PubMed ID: 3893925
[TBL] [Abstract][Full Text] [Related]
15. The Influence of Electrostatic Controls on MDI Size Distribution Measurements.
Stein SW; Rasmussen J; Walls S; Schultz DW; Oakley C; Drake JB
AAPS PharmSciTech; 2019 Apr; 20(5):170. PubMed ID: 31004248
[TBL] [Abstract][Full Text] [Related]
16. Oropharyngeal deposition and delivery aspects of metered-dose inhaler aerosols.
Kim CS; Eldridge MA; Sackner MA
Am Rev Respir Dis; 1987 Jan; 135(1):157-64. PubMed ID: 3800143
[TBL] [Abstract][Full Text] [Related]
17. Particle size study of nine metered dose inhalers, and their deposition probabilities in the airways.
Bouchikhi A; Becquemin MH; Bignon J; Roy M; Teillac A
Eur Respir J; 1988 Jun; 1(6):547-52. PubMed ID: 3169224
[TBL] [Abstract][Full Text] [Related]
18. In-vitro and in-vivo respiratory deposition of a developed metered dose inhaler formulation of an anti-migraine drug.
Abdou EM; Kandil SM; Morsi A; Sleem MW
Drug Deliv; 2019 Dec; 26(1):689-699. PubMed ID: 31274014
[TBL] [Abstract][Full Text] [Related]
19. The delivery of chlorofluorocarbon-propelled versus hydrofluoroalkane-propelled beclomethasone dipropionate aerosol to the mechanically ventilated patient: a laboratory study.
Mitchell JP; Nagel MW; Wiersema KJ; Doyle CC; Migounov VA
Respir Care; 2003 Nov; 48(11):1025-32. PubMed ID: 14585114
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in the management of obstructive airways disease. Auxiliary MDI aerosol delivery systems.
Sackner MA; Kim CS
Chest; 1985 Aug; 88(2 Suppl):161S-170S. PubMed ID: 4017697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
